BiomX Inc. financial data

Symbol
PHGE on NYSE
Location
22 Einstein St., Floor 4, Ness Ziona, Israel
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2025 - Nov 12, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 260 % -22.7%
Return On Equity -191 % -223%
Return On Assets -97.7 % -560%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 29M shares +59.6%
Common Stock, Shares, Outstanding 26.8M shares +47.4%
Entity Public Float 21.4M USD +29.4%
Common Stock, Value, Issued 7K USD +16.7%
Weighted Average Number of Shares Outstanding, Basic 31.4M shares +91.9%
Weighted Average Number of Shares Outstanding, Diluted 31.4M shares +91.6%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 22.8M USD +8.65%
General and Administrative Expense 10.4M USD -8.76%
Operating Income (Loss) -40.4M USD -22%
Nonoperating Income (Expense) 84K USD -74.7%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -37.4M USD -330%
Income Tax Expense (Benefit) 3K USD
Net Income (Loss) Attributable to Parent -37.4M USD -329%
Earnings Per Share, Basic 0 USD/shares -101%
Earnings Per Share, Diluted 1 USD/shares -84.8%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 6.92M USD -70.6%
Other Assets, Current 954K USD -74%
Assets, Current 8.86M USD -68.7%
Property, Plant and Equipment, Net 3M USD -54.4%
Operating Lease, Right-of-Use Asset 2.09M USD -78.4%
Goodwill 801K USD
Other Assets, Noncurrent 96K USD
Assets 26.2M USD -56.4%
Accounts Payable, Current 1.36M USD -2.58%
Liabilities, Current 5.23M USD -41.6%
Contract with Customer, Liability, Noncurrent 1.98M USD 0%
Operating Lease, Liability, Noncurrent 5.29M USD -38.9%
Other Liabilities, Noncurrent 34K USD -78.9%
Accumulated Other Comprehensive Income (Loss), Net of Tax -143M USD -22.7%
Retained Earnings (Accumulated Deficit) -204M USD -22.5%
Stockholders' Equity Attributable to Parent 10.5M USD -72.3%
Liabilities and Equity 26.2M USD -56.4%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -8.71M USD +23.3%
Net Cash Provided by (Used in) Financing Activities 11.9M USD -69.4%
Net Cash Provided by (Used in) Investing Activities 51K USD -92.3%
Common Stock, Shares Authorized 750M shares 0%
Common Stock, Shares, Issued 26.8M shares +47.4%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -2.01M USD +88.4%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 8.07M USD -67.3%
Interest Paid, Excluding Capitalized Interest, Operating Activities 5K USD -99.6%
Deferred Tax Assets, Valuation Allowance 48.8M USD +51.9%
Deferred Tax Assets, Gross 55.6M USD +67.8%
Operating Lease, Liability 9.58M USD +145%
Depreciation 236K USD +3.06%
Payments to Acquire Property, Plant, and Equipment 10K USD -50%
Lessee, Operating Lease, Liability, to be Paid 12.5M USD +164%
Property, Plant and Equipment, Gross 10.5M USD +42.8%
Operating Lease, Liability, Current 1.3M USD +18.2%
Lessee, Operating Lease, Liability, to be Paid, Year Two 1.98M USD +188%
Lessee, Operating Lease, Liability, to be Paid, Year One 1.95M USD +184%
Operating Lease, Weighted Average Discount Rate, Percent 0.06 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 2.95M USD +246%
Lessee, Operating Lease, Liability, to be Paid, Year Three 2.02M USD +193%
Deferred Tax Assets, Operating Loss Carryforwards 42.5M USD +46.2%
Preferred Stock, Shares Issued 148K shares -0.15%
Preferred Stock, Shares Authorized 1M shares 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four 5.05M USD +634%
Operating Lease, Payments 134K USD
Additional Paid in Capital 195M USD +5.39%
Preferred Stock, Shares Outstanding 148K shares -0.15%
Share-based Payment Arrangement, Expense 2.56M USD -47.2%
Interest Expense 2.69M USD +23.7%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%